Spot Trading’s West Pharmaceutical WST Stock Holding History

Spot Trading’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-3,000	Closed	-$162K	–	4132
2015 Q3	$162K	Buy	+3,000	New	+$175K	﹤0.01%	2813

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Spot Trading's WST Position: Q4 2015 in Review

Spot Trading sold out of West Pharmaceutical (WST) in Q4 2015, closing a stake of 700 shares — an estimated $38K sold.

Spot Trading first reported a position in WST in Q3 2015 and held it in 1 quarter. The position peaked at $38K in Q3 2015. 248 funds tracked by Wall St. Rank hold WST as of Q4 2015.

Spot Trading reported no remaining West Pharmaceutical position as of Q4 2015 after selling out during the quarter.
Spot Trading sold 700 West Pharmaceutical shares in Q4 2015, an estimated $38K.
Spot Trading first reported a position in West Pharmaceutical in Q3 2015 and held it in 1 quarter.
Spot Trading's West Pharmaceutical position peaked at $38K in Q3 2015.
248 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2015.

Based on Spot Trading's 13F filing for Q4 2015, filed 29 Jan 2016.